semaglutide

FDA Drug Profile — Ozempic, WEGOVY, OZEMPIC

semaglutide is listed in the FDA National Drug Code directory with 79 NDC codes, marketed under brand names including Ozempic, WEGOVY, OZEMPIC. Available dosage forms: powder, injection, solution, tablet.

Drug details

Generic Name
semaglutide
Brand Names
Ozempic, WEGOVY, OZEMPIC
Application Number
NDA209637
Sponsor
Arene Life Sciences Private Limited
NDC Codes
79
Dosage Forms
POWDER, INJECTION, SOLUTION, TABLET
Routes
SUBCUTANEOUS, ORAL
Active Ingredients
SEMAGLUTIDE

Indications and Usage

1 INDICATIONS AND USAGE OZEMPIC is indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. • to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease. • to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease. OZEMPIC is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) • to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease. ( 1 ) • to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.